Agence de Médecine Préventive, Paris, France.
Vaccine. 2010 Apr 19;28 Suppl 1:A26-30. doi: 10.1016/j.vaccine.2010.02.028.
Multiple health priorities, limited human resources and logistical capacities, as well as expensive vaccines with limited funds available increase the need for evidence-based decision making in immunization programs. The aim of the Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative is to support countries in the establishment or strengthening of National Immunization Technical Advisory Groups (NITAGs) that provide recommendations on immunization policies and programs (e.g., vaccination schedules, improvements of routine immunization coverage, new vaccine introduction, etc.). SIVAC, a program funded by the Bill & Melinda Gates Foundation, is based on a country-driven, step-by-step process that ensures its support is tailored to country needs and emphasizes NITAG sustainability. SIVAC supports countries by reinforcing the capacities of the NITAG scientific and technical secretariat and by providing specific support activities established in consultation with the country and other international partners. Additionally, SIVAC and partners have built an electronic platform, the NITAG Resource Center, that provides information, tools, and briefings to NITAGs and the immunization community.
多种卫生重点事项、有限的人力资源和后勤能力，以及有限资金下昂贵的疫苗，都增加了免疫规划中基于证据的决策的需求。支持独立免疫和疫苗咨询委员会（SIVAC）倡议的目的是支持各国建立或加强国家免疫技术咨询小组（NITAG），就免疫政策和规划（如疫苗接种时间表、常规免疫覆盖率提高、新疫苗引入等）提供建议。SIVAC 是由比尔及梅琳达·盖茨基金会资助的一个项目，它基于国家驱动的、逐步的过程，确保其支持符合国家需求，并强调 NITAG 的可持续性。SIVAC 通过加强 NITAG 科学和技术秘书处的能力，并根据与国家和其他国际合作伙伴协商确定的具体支持活动，来支持各国。此外，SIVAC 和合作伙伴建立了一个电子平台，即 NITAG 资源中心，为 NITAG 和免疫界提供信息、工具和简报。
